Vom Berg J - Search Results

1

Microglia-Centered Combinatorial Strategies Against Glioblastoma.

Martins TA, Schmassmann P, Shekarian T, Boulay JL, Ritz MF, Zanganeh S, Vom Berg J, Hutter G. Martins TA, et al. Among authors: vom berg j. Front Immunol. 2020 Sep 29;11:571951. doi: 10.3389/fimmu.2020.571951. eCollection 2020. Front Immunol. 2020. PMID: 33117364 Free PMC article. Review.

2

Cross-Reactivity and Functionality of Approved Human Immune Checkpoint Blockers in Dogs.

Pantelyushin S, Ranninger E, Guerrera D, Hutter G, Maake C, Markkanen E, Bettschart-Wolfensberger R, Rohrer Bley C, Läubli H, Vom Berg J. Pantelyushin S, et al. Among authors: vom berg j. Cancers (Basel). 2021 Feb 13;13(4):785. doi: 10.3390/cancers13040785. Cancers (Basel). 2021. PMID: 33668625 Free PMC article.

3

IL-12 initiates tumor rejection via lymphoid tissue-inducer cells bearing the natural cytotoxicity receptor NKp46.

Eisenring M, vom Berg J, Kristiansen G, Saller E, Becher B. Eisenring M, et al. Among authors: vom berg j. Nat Immunol. 2010 Nov;11(11):1030-8. doi: 10.1038/ni.1947. Epub 2010 Oct 10. Nat Immunol. 2010. PMID: 20935648

4

New insights into IL-12-mediated tumor suppression.

Tugues S, Burkhard SH, Ohs I, Vrohlings M, Nussbaum K, Vom Berg J, Kulig P, Becher B. Tugues S, et al. Among authors: vom berg j. Cell Death Differ. 2015 Feb;22(2):237-46. doi: 10.1038/cdd.2014.134. Epub 2014 Sep 5. Cell Death Differ. 2015. PMID: 25190142 Free PMC article. Review.

5

Rationale for Combining Bispecific T Cell Activating Antibodies With Checkpoint Blockade for Cancer Therapy.

Kobold S, Pantelyushin S, Rataj F, Vom Berg J. Kobold S, et al. Among authors: vom berg j. Front Oncol. 2018 Jul 25;8:285. doi: 10.3389/fonc.2018.00285. eCollection 2018. Front Oncol. 2018. PMID: 30090763 Free PMC article. Review.

6

Intratumoral IL-12 combined with CTLA-4 blockade elicits T cell-mediated glioma rejection.

Vom Berg J, Vrohlings M, Haller S, Haimovici A, Kulig P, Sledzinska A, Weller M, Becher B. Vom Berg J, et al. J Exp Med. 2013 Dec 16;210(13):2803-11. doi: 10.1084/jem.20130678. Epub 2013 Nov 25. J Exp Med. 2013. PMID: 24277150 Free PMC article.

7

Enzymatic Dissociation Induces Transcriptional and Proteotype Bias in Brain Cell Populations.

Mattei D, Ivanov A, van Oostrum M, Pantelyushin S, Richetto J, Mueller F, Beffinger M, Schellhammer L, Vom Berg J, Wollscheid B, Beule D, Paolicelli RC, Meyer U. Mattei D, et al. Among authors: vom berg j. Int J Mol Sci. 2020 Oct 26;21(21):7944. doi: 10.3390/ijms21217944. Int J Mol Sci. 2020. PMID: 33114694 Free PMC article.

8

Neoadjuvant in situ vaccination with cowpea mosaic virus as a novel therapy against canine inflammatory mammary cancer.

Alonso-Miguel D, Valdivia G, Guerrera D, Perez-Alenza MD, Pantelyushin S, Alonso-Diez A, Beiss V, Fiering S, Steinmetz NF, Suarez-Redondo M, Vom Berg J, Peña L, Arias-Pulido H. Alonso-Miguel D, et al. Among authors: vom berg j. J Immunother Cancer. 2022 Mar;10(3):e004044. doi: 10.1136/jitc-2021-004044. J Immunother Cancer. 2022. PMID: 35277459 Free PMC article.

9

Exit pathways of therapeutic antibodies from the brain and retention strategies.

Schellhammer L, Beffinger M, Salazar U, Laman JD, Buch T, Vom Berg J. Schellhammer L, et al. Among authors: vom berg j. iScience. 2023 Oct 6;26(11):108132. doi: 10.1016/j.isci.2023.108132. eCollection 2023 Nov 17. iScience. 2023. PMID: 37915602 Free PMC article. Review.

10

Delivery of Antibodies into the Murine Brain via Convection-enhanced Delivery.

Beffinger M, Schellhammer L, Pantelyushin S, Vom Berg J. Beffinger M, et al. Among authors: vom berg j. J Vis Exp. 2019 Jul 18;(149). doi: 10.3791/59675. J Vis Exp. 2019. PMID: 31380848

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

24 results

Search Page